Clinical Trials
3 trialsNCT07559474 2026-04-30
A Study to Assess the Safety and Pharmacokinetics of INCB123667 When Administered Orally to Adult Participants With Moderate or Severe Hepatic Impairment
Incyte Corporation
Phase 1 Not yet recruiting
NCT07550634 2026-04-24
Pharmacokinetics and Safety of MDR-001 in Mild and Moderate Hepatic Impairment
MindRank AI Ltd
Phase 1 Not yet recruiting
NCT05209295 2026-01-12
A Study to Evaluate CC-486/Onureg in Participants With Moderate or Severe Hepatic Impairment Compared With Normal Hepatic Function in Participants With Myeloid Malignancies
Bristol-Myers Squibb
Phase 1 Terminated